Viatris Completes All Previously Announced Divestitures with the Closing of its OTC Business Divestiture
DENVER, Colo., Jul 03, 2024 (247marketnews.com)- Viatris Inc. (NASDAQ:VTRS) stated that it closed the divestiture of its Over-the-Counter (OTC) business to Cooper Consumer Health, which brings to substantial completion all of the divestitures announced in October.
Scott Smith, Chief Executive Officer of Viatris, stated, “Closing the divestiture of our OTC business is a significant milestone in the execution of our strategic plan.
“With all our previously announced divestitures now substantially complete, Viatris is stronger and more streamlined. We look forward to an exciting future in which we continue to build on our very strong base business and add to our innovative product pipeline to drive strong future revenue growth and positively affect even more patients’ lives worldwide.”
About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.
24/7 MARKET NEWS, INC Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.
CONTACT:
24/7 Market News
Editor@247marketnews.com
Related news for (VTRS)
- Viatris Appoints Andrew Enrietti as Chief Administrative and Transformation Officer
- Viatris Announces Approval of First Generic Iron Sucrose Injection in the U.S.
- Viatris Reports Second Quarter 2025 Results and Reiterates 2025 Financial Guidance
- Viatris Announces Quarterly Dividend
- Viatris Announces Appointment of David Simmons to the Company’s Board of Directors